drugset / Trial / NCT05284942

Central China Rosai-Dorfman Disease Registry

NCT05284942

Phase 4 Unknown 20 enrolled Tongji Hospital
NaSingle-groupTreatment

Summary

This is a research study among patients with Rosai-Dorfman disease.

Timeline

Start
2011-10-01
Primary completion
2022-06-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule 500 mg Oral
Background Prednisone Other / unclassified 5 mg Oral
Background Prednisone Other / unclassified 15 mg Oral